Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor.
about
In Vivo pO2 Imaging of Tumors: Oxymetry with Very Low-Frequency Electron Paramagnetic ResonancePerfluorocarbon nanoparticles for physiological and molecular imaging and therapyNanomedicine strategies for molecular targets with MRI and optical imaging.129 Xe chemical shift in human blood and pulmonary blood oxygenation measurement in humans using hyperpolarized 129 Xe NMR.Oxygen Mapping within Healthy and Acutely Infarcted Brain Tissue in Humans Using the NMR Relaxation of Lipids: A Proof-Of-Concept Translational Study.Repetitive tissue pO2 measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studiesProton imaging of siloxanes to map tissue oxygenation levels (PISTOL): a tool for quantitative tissue oximetry.Solid MRI contrast agents for long-term, quantitative in vivo oxygen sensing.GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.Imaging tumor hypoxia by magnetic resonance methods.In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygenCurrent issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia.The role of functional and molecular imaging in cancer drug discovery and development.Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.Blood oxygen level-dependent MR imaging of the kidneys.Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.Quantitative diffuse reflectance and fluorescence spectroscopy: tool to monitor tumor physiology in vivoMapping in vivo tumor oxygenation within viable tumor by 19F-MRI and multispectral analysis.Temporal variation in the response of tumors to hyperoxia with breathing carbogen and oxygen.Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical SettingsAnti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.Quantitative magnetic resonance fluorine imaging: today and tomorrow.New frontiers and developing applications in 19F NMR.Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat modelA role for dynamic contrast-enhanced magnetic resonance imaging in predicting tumour radiation response.Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.Application of in vivo EPR for tissue pO2 and redox measurementsCorrelations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation responseMonitoring and Targeting Anti-VEGF Induced Hypoxia within the Viable Tumor by 19F-MRI and Multispectral Analysis.In vivo mapping of tumor oxygen consumption using (19)F MRI relaxometry.Noninvasive mapping of spontaneous fluctuations in tumor oxygenation using 19F MRI.Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear (1) H/(19) F MRI and perfluorocarbon nanoparticles.An oxygen-consuming phantom simulating perfused tissue to explore oxygen dynamics and (19)F MRI oximetry.Dynamic breast tumor oximetry: the development of prognostic radiology.Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model.Noninvasive measurement of renal oxygen extraction fraction under the influence of respiratory challenge.Tumor hypoxia imaging.
P2860
Q26782107-92E984AB-F665-4EE0-94C2-705BE1180F7EQ30426880-6817E084-6F13-43FD-A3BA-1A80EE503F9DQ30481471-B4658939-1BA5-4F28-86A6-206FE4A18CA4Q30489210-AFACA3F6-9FCC-46E9-B069-630C5E92556BQ30987006-9D3F71CC-68EB-4538-ADEB-D7FE1C43EDB7Q31114143-B1290CD5-73FE-4C01-AA72-4312DFBADD03Q31160148-44EDA6E0-FEBC-48DC-8FEC-55E60CC1FCE2Q33607091-81F750AA-9B4A-492E-9F36-9B3D93BE367AQ33704904-91C6C71F-8A99-4DE2-9024-BD397A67ED7DQ33801254-396C9ECB-D8AA-4FC3-A3B7-8BB99BD2E373Q34249620-97E9E1B4-C507-42AF-A9FB-B0E9DB9A3832Q35645306-0A0F09F0-A253-4692-BCD4-DBAAA30ADE62Q35861042-082F6FCA-F09F-4EF8-9E27-B6EC824C8BBDQ35968111-08356B85-10E9-41F9-A856-0E68E59E3A0BQ37003678-5017CED5-6F92-4104-9BD2-D5C41A6E964FQ37109541-E329A311-A02D-4767-9ED4-0F04DF433970Q37120352-8A5ED83A-FA53-4FE4-9156-98943742EFEEQ37297515-A5ACF7DF-C5BF-4CAE-9A29-132EB354EA2CQ37299659-DE9C7556-61EA-4085-9C85-62CA77760687Q37382526-7075AD64-10D5-44C0-B127-B6AD5D3F8226Q37415346-AE6E117D-6F59-44D5-BE58-5A806F46AEC7Q37604088-4D011F5A-6C19-444A-8E38-32C2AEB1B2AAQ37668312-546501EB-AE24-4E5F-B2CF-5B49CF326012Q37766558-6747BEF6-0DDF-4BB8-96C4-293DBA643C32Q38094240-88CD2A27-B3F3-4107-9079-C278E99873C5Q38625581-F1581CF7-38FD-4A7E-9DD0-A85F1988E1E1Q39799440-0FAFB2F9-CBBD-4740-A786-6EA445DEE673Q40631313-41BC3C52-82E5-46C8-8BE2-7D4E1C473929Q41104365-4EB3ECD3-5262-4C7F-B453-8869625862B7Q41784125-A17052AE-948A-413A-822B-C821FBB54959Q42264735-B0E85CFE-AAC9-4BDB-9051-772038F7966DQ42477899-28BABF8B-7692-4695-A60B-9F31957E1A10Q42480100-1BAAB9DD-6C47-46DC-945C-2DF32D23964EQ42722030-24C8FAF0-6FE4-4F20-B8EC-F6ED706FB580Q43005872-FCC27F5C-4084-4F59-AE9F-5DF23E98777FQ44354895-79D108D6-D254-4D8D-8593-15892126CD43Q46697879-9A0DBDB4-FE8A-42E2-8B53-E3CA468AE72BQ51549701-1A6464E1-45AD-4A0A-BE71-223BACC8D6B3Q53272680-63467E3C-6EE8-4EB9-B157-D0F3B52C4087
P2860
Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tumor oximetry: demonstration ...... prostate R3327-AT1 rat tumor.
@ast
Tumor oximetry: demonstration ...... prostate R3327-AT1 rat tumor.
@en
type
label
Tumor oximetry: demonstration ...... prostate R3327-AT1 rat tumor.
@ast
Tumor oximetry: demonstration ...... prostate R3327-AT1 rat tumor.
@en
prefLabel
Tumor oximetry: demonstration ...... prostate R3327-AT1 rat tumor.
@ast
Tumor oximetry: demonstration ...... prostate R3327-AT1 rat tumor.
@en
P2093
P1476
Tumor oximetry: demonstration ...... prostate R3327-AT1 rat tumor.
@en
P2093
P304
P356
10.1016/S0360-3016(00)01460-7
P407
P577
2001-03-01T00:00:00Z